Because activation of the NFκB pathway plays an important role in the development of liver fibrosis from the fatty liver [17], determining how rapamycin affects the NFκB pathway in rapamycin-induced fatty liver is necessary to assess the undesired side effects of rapamycin as an anti-aging drug. Here, NFKB1 is linked to Hepatic fibrosis.